Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Cemil, Bilir"'
Autor:
Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, Arda Ulaş Mutlu, Muhammed Mustafa Atcı, Abdullah Sakin, İrem Öner, Havva Yeşil Çınkır, Melek Karakurt Eryılmaz, Dilek Çağlayan, Onur Yazdan Balçık, Nail Paksoy, Senem Karabulut, Derya Kıvrak Salim, Cemil Bilir, Miraç Özen, Melike Özçelik, Ali Arıcan, Baran Akagündüz, Ali İnal, Dinçer Aydın, Leyla Özer, Ahmet Gülmez, Nazım Serdar Turhal, Selin Aktürk Esen, Efnan Algın, Sinem Akbaş, Yakup İriağaç, Teoman Şakalar, Çağlar Ünal, Özlem Er, Şaban Seçmeler, Mustafa Bozkurt
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The optimal treatment for metastatic colorectal cancer (mCRC) after the second line is still controversial. Regorafenib has been the standard of care in this setting as it improved overall survival (OS) compared to placebo. In rea
Externí odkaz:
https://doaj.org/article/7d19cca4236d429b8424cc6bef6070f5
Autor:
Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, Arda Ulaş Mutlu, Muhammed Mustafa Atcı, Abdullah Sakin, İrem Öner, Havva Yeşil Çınkır, Melek Karakurt Eryılmaz, Dilek Çağlayan, Onur Yazdan Balçık, Nail Paksoy, Senem Karabulut, Derya Kıvrak Salim, Cemil Bilir, Miraç Özen, Melike Özçelik, Ali Arıcan, Baran Akagündüz, Ali İnal, Dinçer Aydın, Leyla Özer, Ahmet Gülmez, Nazım Serdar Turhal, Selin Aktürk Esen, Efnan Algın, Sinem Akbaş, Yakup İriağaç, Teoman Şakalar, Çağlar Ünal, Özlem Er, Şaban Seçmeler, Mustafa Bozkurt
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/3738f873f38f42ca820c7d9a886f1eba
Autor:
Ayşe Demirci, Cemil Bilir, Burcu Gülbağcı, İlhan Hacıbekiroğlu, İbrahim V. Bayoğlu, İrem Bilgetekin, Sinan Koca, Havva Y. Çınkır, Nadiye Akdeniz, Deniz Gül, Ceyhun Varım, Umut Demirci, Berna Öksüzoğlu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract To compare enzalutamide (E) and abiraterone acetate (AA) in terms of efficacy, survival and to characterize prognostic factors affecting survival in metastatic castration-resistant prostate cancer (mCRPC) patients. A total of 250 patients tr
Externí odkaz:
https://doaj.org/article/2f1961a10d9b47f5b41b353c34cd4036
Publikováno v:
Sakarya Tıp Dergisi, Vol 11, Iss 1, Pp 129-136 (2021)
Amaç: Bu çalışmanın amacı baş boyun kanserli (BBK) hastalarımızın genel özelliklerini, risk faktörlerini, tedavi modalitelerini gözden geçirmek ve sağkalımlarını hesaplayıp sağkalımı ve tedavi sonuçlarını etkileyen faktörler
Externí odkaz:
https://doaj.org/article/107014aa7bf34090a45b7cd10f129963
Publikováno v:
Translational Oncology, Vol 15, Iss 1, Pp 101243- (2022)
The therapeutic effects of abemaciclib (ABE), an inhibitor of cyclin- dependent kinases (CDK) 4/6, on the proliferation of two types of prostate cancer (PC) cells were revealed. In this study, in vitro cytotoxic and apoptotic effects of ABE on metast
Externí odkaz:
https://doaj.org/article/8da482e5e9ad4d8193a50b849235c240
Publikováno v:
Sakarya Tıp Dergisi, Vol 9, Iss 1, Pp 92-102 (2019)
Amaç: Meme kanseri kadınlarda en sık görülen ve farklı alt tiplere ayrılan heterojen bir kanser türüdür. Bu nedenle, meme kanseri alt tiplerine özgü tedavi yaklaşımları dikkat çekmektedir. Mevcut çalışmada, kemik metastazı görül
Externí odkaz:
https://doaj.org/article/fe73caf7fe4949d6a3342ebedced2685
Publikováno v:
Journal of Oncological Sciences, Vol 3, Iss 3, Pp 107-111 (2017)
Although positron emission tomography–computed tomography (PET/CT) is widely used for staging, there are limited data available to describe exactly the role of PET/CT metabolic and quantitative parameters for the prediction of disease outcome. A to
Externí odkaz:
https://doaj.org/article/299bfd75ddb3415fa80f24afd85caad7
Publikováno v:
Current Medical Imaging Formerly Current Medical Imaging Reviews. 18:1079-1085
Background: Pancreatic cancer is mostly diagnosed in advanced stages, and treatment results are not satisfactory. L3 skeletal muscle index (SMI) has emerged as a prognostic factor in pancreatic cancer patients. We aimed to assess the association betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4e1b490338cc7b8729d6f24c30b5d31
https://doi.org/10.2174/1573405618666220303105410
https://doi.org/10.2174/1573405618666220303105410
Autor:
Cemil Bilir, M.D., Can Sarisozen, PhD
Publikováno v:
Journal of Oncological Sciences, Vol 3, Iss 2, Pp 52-56 (2017)
Tryptophan (Trp) is one of the important essential amino acids and Kynurenine pathway (KP) is the first and rate limiting step of degrading Trp to active metabolites. Recent studies showed that KP metabolites have antimicrobial and immunosuppressive
Externí odkaz:
https://doaj.org/article/cd1b33ed7905478b9e264aab32f5ebc8
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 22, Iss 1 (2019)
Purpose: Toll-like receptor 4 (TLR4) is over-expressed in breast tumors and thus contributing to the tumor progression and metastasis. Natural products have drawn attention in cancer immunotherapy due to their various biological activities. Curcumin
Externí odkaz:
https://doaj.org/article/1f79a51e30534bbdaee02f3176995d2e